Heparin,Myeloperoxidase,and Atherosclerosis

Nicholls SJ , Hazen SL Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 2005;25:1102.

McMillen TS , Heinecke JW , LeBoeuf RC Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice. Circulation 2005;111:2798.

Elsayed E. , Becker RC The impact of heparin compounds on cellular inflammatory responses: A construct for future investigation and pharmaceutical development. J Thromb Thrombolysis 2003;15:11.

Baldus S. , Eiserich JP , Mani A. , et al. Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration. J Clin Invest 2001;108:1759.

Daphna EM , Michaela S. , Eynat P. , et al. Association of myeloperoxidase with heparin: Oxidative inactivation of proteins on the surface of endothelial cells by the bound enzyme. Mol Cell Biochem 1998;183:55.

Bos JC , Grooteman Mpc , van Houte AJ , et al. Low polymorphonuclear cell degranulation during citrate anticoagulation: A comparison between citrate and heparin dialysis. Nephrol Dial Transplant 1997;12:1387.

Inose K. , Ono K. , Tsuchida A. , et al. Active inhibitory effect of nafamostat mesylate against the elevation of plasma myeloperoxidase during hemodialysis. Nephron 1997;75: 420.

Baldus S. , Rudolph V. , Roiss M. , et al. Heparins increase endothelial nitric oxide bioavailability by liberating vessel-immobilized myeloperoxidase. Circulation 2006; 113:1871.

Borawski J. Myeloperoxidase as a marker of hemodialysis biocompatibility and oxidative stress: the underestimated modifying effects of heparin. Am J Kidney Dis 2006;47:37.

Borawski J. , Naumnik B. , Rydzewska-Rosolowska A. , Mysliwiec M. Myeloperoxidase up-regulation during haemodialysis: is heparin the missing link? Nephrol Dial Transplant 2006;21:128.